UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.

The UCSF community is deeply saddened to learn about the passing of Richard Havel, MD, a world-renowned researcher in the field of lipoproteins and the former director of the UCSF Cardiovascular Research Institute.

It started with a small but persistent noise in her right ear. After other doctors failing to identify the source of the noise, clinicians at UCSF were able to inform the patient that she had a dural arteriovenous fistula in her right sigmoid sinus.

In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.

Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.

Oncologist Lawrence Fong is leading UCSF’s newly launched Cancer Immunotherapy Program, a clinic and laboratory dedicated to developing and studying cutting-edge immunotherapy treatments.

Clinicians at UCSF are taking on trauma as more than just a social issue. They are addressing how it has a staggering impact on a person’s health.

UCSF and UC Hastings College of the Law have combined their expertise to offer a new degree program: the Masters of Science program in Health Policy and Law, which begins classes in August.